Healthcare Sector Stocks
The Healthcare sector has a total of 1046 stocks, with a combined market cap of $9.11 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 47.63.
Market Cap
9.11T
Revenue
4.67T
Profits
191.22B
PE Ratio
47.63
Profit Margin
4.10%
Dividend Yield
0.39%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | -1.26% | 1,068,635 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 623.78B | -2.23% | 3,139,772 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 460.56B | -0.37% | 1,484,140 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 354.36B | -1.16% | 2,835,057 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 327.43B | -0.62% | 2,043,519 | 450.53B |
| 6 | NVS | Novartis AG | 273.28B | -0.61% | 974,849 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 252.87B | -1.84% | 1,757,508 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 243.41B | -2.48% | 1,242,950 | 46.34B |
| 9 | AMGN | Amgen Inc. | 222.13B | -2.52% | 941,912 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 183.67B | -0.62% | 1,525,501 | 30.46B |
| 11 | ABT | Abbott Laboratories | 168.92B | -1.22% | 3,330,254 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 167.11B | -0.71% | 7,363,943 | 50.34B |
| 13 | PFE | Pfizer Inc. | 160.87B | -1.03% | 13,786,062 | 63.70B |
| 14 | DHR | Danaher Corporation | 150.24B | -3.53% | 2,158,748 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 142.16B | -1.04% | 668,721 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 129.00B | -2.65% | 329,521 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 125.68B | -1.40% | 4,711,625 | 49.19B |
| 18 | MDT | Medtronic plc | 109.66B | -0.65% | 15,643,838 | 37.54B |
| 19 | CVS | CVS Health Corporation | 109.45B | -0.13% | 2,383,173 | 412.65B |
| 20 | SYK | Stryker Corporation | 104.71B | -0.88% | 1,289,823 | 25.84B |
| 21 | MCK | McKesson Corporation | 104.13B | 4.60% | 519,801 | 410.98B |
| 22 | SNY | Sanofi | 98.83B | -0.92% | 4,677,705 | 55.89B |
| 23 | GSK | GSK plc | 97.46B | -1.38% | 5,943,781 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 91.94B | -0.48% | 454,256 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 83.15B | -1.40% | 443,986 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 76.97B | 0.12% | 10,710,165 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 74.09B | -2.15% | 560,275 | 15.53B |
| 28 | CI | The Cigna Group | 70.67B | -1.62% | 918,576 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 62.85B | -0.64% | 5,974,569 | 21.00B |
| 30 | ARGX | argenx SE | 60.14B | -1.73% | 134,282 | 5.32B |
| 31 | NTRA | Natera, Inc. | 59.76B | 0.31% | 909,159 | 2.71B |
| 32 | COR | Cencora, Inc. | 59.02B | 3.01% | 765,719 | 332.77B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 58.23B | -1.32% | 1,219,725 | 28.42B |
| 34 | CAH | Cardinal Health, Inc. | 52.92B | 2.94% | 750,121 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 48.99B | -1.53% | 1,066,398 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 48.45B | -0.62% | 448,878 | 22.48B |
| 37 | A | Agilent Technologies, Inc. | 47.38B | -2.47% | 840,920 | 7.37B |
| 38 | VEEV | Veeva Systems Inc. | 46.19B | -0.07% | 447,645 | 3.46B |
| 39 | MDLN | Medline Inc. | 45.74B | 0.26% | 4,179,673 | 29.94B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 45.63B | -1.12% | 2,155,497 | 17.32B |
| 41 | HUM | Humana Inc. | 45.47B | -0.75% | 412,097 | 145.68B |
| 42 | RVMD | Revolution Medicines, Inc. | 44.85B | 1.95% | 965,063 | - |
| 43 | IQV | IQVIA Holdings Inc. | 43.05B | -2.72% | 526,699 | 16.98B |
| 44 | WAT | Waters Corporation | 42.21B | -2.22% | 272,384 | 4.64B |
| 45 | ONC | BeOne Medicines AG | 41.15B | -1.09% | 164,912 | 6.13B |
| 46 | IDXX | IDEXX Laboratories, Inc. | 41.12B | -0.04% | 111,701 | 4.55B |
| 47 | ILMN | Illumina, Inc. | 40.22B | -2.67% | 848,622 | 4.49B |
| 48 | HLN | Haleon plc | 38.15B | -2.94% | 20,881,856 | 14.80B |
| 49 | BIIB | Biogen Inc. | 33.29B | -0.26% | 651,540 | 10.03B |
| 50 | RPRX | Royalty Pharma plc | 33.03B | -1.58% | 1,178,079 | 2.54B |
| 51 | DXCM | DexCom, Inc. | 32.61B | 0.14% | 1,319,859 | 4.97B |
| 52 | RMD | ResMed Inc. | 31.93B | 0.95% | 394,404 | 5.65B |
| 53 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.57B | -4.38% | 911,575 | 4.80B |
| 54 | ALC | Alcon Inc. | 30.76B | -1.81% | 1,310,413 | 10.86B |
| 55 | CNC | Centene Corporation | 30.32B | -1.21% | 1,730,110 | 180.30B |
| 56 | MTD | Mettler-Toledo International Inc. | 29.73B | -1.80% | 60,904 | 4.13B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 29.06B | -1.58% | 1,073,842 | 21.27B |
| 58 | ZTS | Zoetis Inc. | 28.80B | -0.19% | 2,030,901 | 9.53B |
| 59 | ROIV | Roivant Sciences Ltd. | 26.15B | -1.01% | 1,159,461 | 7.53M |
| 60 | WST | West Pharmaceutical Services, Inc. | 25.70B | -1.49% | 316,804 | 3.33B |
| 61 | DGX | Quest Diagnostics Incorporated | 25.55B | -0.67% | 449,789 | 11.56B |
| 62 | UTHR | United Therapeutics Corporation | 24.95B | 7.34% | 1,046,866 | 3.15B |
| 63 | LH | Labcorp Holdings Inc. | 24.86B | -0.50% | 194,883 | 14.35B |
| 64 | BNTX | BioNTech SE | 24.52B | -0.70% | 325,216 | 3.03B |
| 65 | INSM | Insmed Incorporated | 24.23B | -2.80% | 1,133,064 | 1.14B |
| 66 | INCY | Incyte Corporation | 24.08B | -2.12% | 868,644 | 5.82B |
| 67 | PHG | Koninklijke Philips N.V. | 24.00B | -2.54% | 756,955 | 20.18B |
| 68 | GH | Guardant Health, Inc. | 23.50B | -1.82% | 882,254 | 1.18B |
| 69 | GMAB | Genmab A/S | 21.27B | -1.91% | 4,128,759 | 4.13B |
| 70 | THC | Tenet Healthcare Corporation | 20.50B | -0.38% | 150,219 | 21.81B |
| 71 | STE | STERIS plc | 20.39B | -0.41% | 191,875 | 6.04B |
| 72 | VTRS | Viatris Inc. | 20.31B | -0.23% | 3,063,505 | 14.74B |
| 73 | RVTY | Revvity, Inc. | 17.04B | -0.13% | 488,138 | 2.91B |
| 74 | MEDP | Medpace Holdings, Inc. | 16.87B | -3.17% | 99,673 | 2.78B |
| 75 | ZBH | Zimmer Biomet Holdings, Inc. | 16.75B | -1.11% | 769,394 | 8.51B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.10B | 0.51% | 369,522 | 4.60B |
| 77 | ASND | Ascendis Pharma A/S | 14.95B | -0.08% | 446,316 | 1.20B |
| 78 | SOLV | Solventum Corporation | 14.79B | -1.44% | 201,158 | 8.31B |
| 79 | EXEL | Exelixis, Inc. | 14.43B | -0.29% | 633,171 | 2.44B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.42B | 0.04% | 890,387 | 3.37B |
| 81 | SMMT | Summit Therapeutics Inc. | 13.82B | 2.42% | 4,056,259 | - |
| 82 | TEM | Tempus AI, Inc. | 13.80B | -6.61% | 4,628,817 | 1.43B |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.76B | -2.33% | 278,481 | 4.00B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 12.98B | 0.88% | 1,180,155 | 713.07M |
| 85 | PEN | Penumbra, Inc. | 12.54B | 0.04% | 149,859 | 1.50B |
| 86 | ICLR | ICON Public Limited Company | 12.46B | -4.98% | 330,587 | 8.29B |
| 87 | CORT | Corcept Therapeutics Incorporated | 12.39B | -0.53% | 377,165 | 830.81M |
| 88 | HALO | Halozyme Therapeutics, Inc. | 12.29B | -1.88% | 1,059,335 | 1.66B |
| 89 | BAX | Baxter International Inc. | 12.26B | -1.21% | 2,400,813 | 11.47B |
| 90 | TWST | Twist Bioscience Corporation | 12.06B | -0.51% | 1,310,354 | 431.80M |
| 91 | EHC | Encompass Health Corporation | 11.92B | -0.35% | 296,532 | 6.21B |
| 92 | BTSG | BrightSpring Health Services, Inc. | 11.91B | 0.75% | 1,065,545 | 14.37B |
| 93 | FMS | Fresenius Medical Care AG | 11.91B | -0.58% | 289,470 | 22.19B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.58B | -0.54% | 78,317 | 1.28B |
| 95 | TXG | 10x Genomics, Inc. | 11.45B | -2.76% | 1,765,640 | 616.91M |
| 96 | DVA | DaVita Inc. | 11.43B | 2.50% | 254,685 | 14.01B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 11.40B | -1.85% | 809,470 | 3.41B |
| 98 | TECH | Bio-Techne Corporation | 11.36B | -0.03% | 1,422,819 | 1.22B |
| 99 | SNN | Smith & Nephew plc | 10.92B | -1.65% | 829,015 | 6.30B |
| 100 | COO | The Cooper Companies, Inc. | 10.91B | 1.49% | 1,872,767 | 4.24B |
| 101 | ELAN | Elanco Animal Health Incorporated | 10.90B | -2.52% | 3,027,540 | 5.02B |
| 102 | RDY | Dr. Reddy's Laboratories Limited | 10.43B | -2.38% | 1,930,847 | 3.50B |
| 103 | UHS | Universal Health Services, Inc. | 10.35B | 0.75% | 220,181 | 18.11B |
| 104 | ALGN | Align Technology, Inc. | 10.32B | -0.03% | 257,134 | 4.14B |
| 105 | AVTR | Avantor, Inc. | 10.10B | -0.73% | 4,373,938 | 6.56B |
| 106 | RGEN | Repligen Corporation | 10.10B | -6.89% | 878,938 | 785.10M |
| 107 | GMED | Globus Medical, Inc. | 10.02B | -0.35% | 580,403 | 3.14B |
| 108 | IBRX | ImmunityBio, Inc. | 9.85B | -1.54% | 7,737,527 | 165.79M |
| 109 | KRYS | Krystal Biotech, Inc. | 9.78B | -0.61% | 88,855 | 440.48M |
| 110 | ENSG | The Ensign Group, Inc. | 9.78B | -1.63% | 226,898 | 5.49B |
| 111 | GKOS | Glaukos Corporation | 9.69B | 0.13% | 319,145 | 612.84M |
| 112 | KYMR | Kymera Therapeutics, Inc. | 9.59B | 3.19% | 518,420 | 105.00M |
| 113 | MOH | Molina Healthcare, Inc. | 9.59B | -2.69% | 439,170 | 42.47B |
| 114 | AXSM | Axsome Therapeutics, Inc. | 9.56B | -1.05% | 384,971 | 776.57M |
| 115 | BIO | Bio-Rad Laboratories, Inc. | 9.50B | -5.96% | 135,042 | 2.59B |
| 116 | BRKR | Bruker Corporation | 9.49B | -3.80% | 876,510 | 3.50B |
| 117 | HSIC | Henry Schein, Inc. | 9.45B | 0.93% | 320,764 | 13.60B |
| 118 | OSCR | Oscar Health, Inc. | 9.34B | -1.77% | 1,431,975 | 15.32B |
| 119 | CYTK | Cytokinetics, Incorporated | 9.29B | 1.42% | 749,643 | 67.67M |
| 120 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.25B | 0.05% | 589,880 | 669.50M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.24B | 1.39% | 378,963 | 281.99M |
| 122 | PODD | Insulet Corporation | 9.08B | 0.33% | 511,490 | 3.05B |
| 123 | QGEN | Qiagen N.V. | 8.74B | -3.40% | 1,095,733 | 2.10B |
| 124 | ABVX | ABIVAX Société Anonyme | 8.69B | -2.64% | 713,881 | 5.33M |
| 125 | PCVX | Vaxcyte, Inc. | 8.47B | -0.02% | 675,123 | - |
| 126 | SYRE | Spyre Therapeutics, Inc. | 8.26B | 5.21% | 780,813 | - |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 8.11B | -0.29% | 142,422 | 7.46M |
| 128 | CAI | Caris Life Sciences, Inc. | 8.09B | -6.48% | 1,816,225 | 989.61M |
| 129 | HNGE | Hinge Health, Inc. | 7.89B | 0.51% | 464,032 | 720.06M |
| 130 | TGTX | TG Therapeutics, Inc. | 7.77B | -1.85% | 1,232,527 | 799.54M |
| 131 | ATR | AptarGroup, Inc. | 7.73B | 0.31% | 151,342 | 3.93B |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.40B | -0.25% | 980,363 | 874.09M |
| 133 | HQY | HealthEquity, Inc. | 7.38B | 0.88% | 315,024 | 1.36B |
| 134 | IMVT | Immunovant, Inc. | 7.11B | 1.84% | 753,273 | - |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 6.97B | -0.70% | 1,180,644 | 3.12B |
| 136 | HIMS | Hims & Hers Health, Inc. | 6.90B | -0.77% | 5,131,511 | 2.58B |
| 137 | ALKS | Alkermes plc | 6.82B | 0.37% | 784,785 | 1.67B |
| 138 | BLTE | Belite Bio, Inc | 6.72B | -1.68% | 71,891 | - |
| 139 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.60B | 0.64% | 288,134 | 239.92M |
| 140 | PACS | PACS Group, Inc. | 6.54B | -0.65% | 322,515 | 5.55B |
| 141 | IOVA | Iovance Biotherapeutics, Inc. | 6.53B | -2.73% | 9,648,796 | 324.97M |
| 142 | CHE | Chemed Corporation | 6.53B | -0.69% | 89,595 | 2.60B |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.50B | 0.09% | 234,899 | 1.56B |
| 144 | GRFS | Grifols, S.A. | 6.50B | -1.16% | 255,369 | 8.48B |
| 145 | CGON | CG Oncology, Inc. | 6.28B | -0.10% | 357,118 | 6.23M |
| 146 | KOD | Kodiak Sciences Inc. | 6.19B | 4.15% | 2,634,669 | - |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.11B | -1.82% | 142,030 | 290.54M |
| 148 | BLCO | Bausch + Lomb Corporation | 6.07B | - | 306,190 | 5.32B |
| 149 | GRAL | GRAIL, Inc. | 6.06B | -3.20% | 567,478 | 165.26M |
| 150 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.89B | 1.13% | 408,061 | 840.85M |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.84B | -0.68% | 404,279 | - |
| 152 | COGT | Cogent Biosciences, Inc. | 5.60B | 0.72% | 711,284 | - |
| 153 | ORKA | Oruka Therapeutics, Inc. | 5.54B | 0.44% | 471,295 | - |
| 154 | MIRM | Mirum Pharmaceuticals, Inc. | 5.54B | -0.25% | 333,962 | 618.07M |
| 155 | MMED | MiniMed Group, Inc. | 5.47B | -0.18% | 1,881,317 | 3.22B |
| 156 | CRSP | CRISPR Therapeutics AG | 5.45B | 1.81% | 527,495 | 13.39M |
| 157 | PTCT | PTC Therapeutics, Inc. | 5.42B | 0.22% | 513,564 | 1.01B |
| 158 | STVN | Stevanato Group S.p.A. | 5.41B | -5.67% | 84,770 | 1.40B |
| 159 | TVTX | Travere Therapeutics, Inc. | 5.39B | -2.94% | 677,595 | 591.33M |
| 160 | RDNT | RadNet, Inc. | 5.36B | -1.12% | 365,568 | 2.27B |
| 161 | TFX | Teleflex Incorporated | 5.34B | 0.85% | 274,869 | 2.25B |
| 162 | SHC | Sotera Health Company | 5.22B | -1.08% | 628,839 | 1.22B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.16B | 0.13% | 346,574 | 1.58B |
| 164 | ERAS | Erasca, Inc. | 5.15B | 0.41% | 1,463,523 | - |
| 165 | DFTX | Definium Therapeutics, Inc. | 5.12B | 0.03% | 943,043 | - |
| 166 | DNTH | Dianthus Therapeutics, Inc. | 5.06B | 2.81% | 264,143 | 1.90M |
| 167 | MANE | Veradermics, Incorporated | 5.04B | -0.49% | 213,037 | - |
| 168 | DOCS | Doximity, Inc. | 5.03B | -0.35% | 1,126,452 | 655.57M |
| 169 | BLLN | BillionToOne, Inc. | 4.93B | -1.82% | 216,764 | 397.41M |
| 170 | WAY | Waystar Holding Corp. | 4.83B | -0.67% | 745,702 | 1.21B |
| 171 | HAE | Haemonetics Corporation | 4.76B | -0.68% | 132,246 | 1.35B |
| 172 | LFST | LifeStance Health Group, Inc. | 4.58B | -0.37% | 1,480,505 | 1.58B |
| 173 | EWTX | Edgewise Therapeutics, Inc. | 4.49B | 1.87% | 467,760 | - |
| 174 | ABCL | AbCellera Biologics Inc. | 4.48B | -5.21% | 4,663,358 | 66.17M |
| 175 | CON | Concentra Group Holdings Parent, Inc. | 4.48B | 1.98% | 276,966 | 2.29B |
| 176 | ADPT | Adaptive Biotechnologies Corporation | 4.40B | -4.57% | 4,289,672 | 308.08M |
| 177 | HTFL | HeartFlow, Inc. | 4.33B | 0.18% | 658,977 | 212.07M |
| 178 | ITGR | Integer Holdings Corporation | 4.30B | 0.09% | 223,460 | 1.84B |
| 179 | INDV | Indivior Pharmaceuticals, Inc. | 4.19B | -0.89% | 406,514 | 1.33B |
| 180 | TNGX | Tango Therapeutics, Inc. | 4.18B | -0.60% | 1,108,758 | 53.81M |
| 181 | LIVN | LivaNova PLC | 4.16B | -1.29% | 371,372 | 1.47B |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.15B | 5.01% | 1,167,183 | 10.35M |
| 183 | ICUI | ICU Medical, Inc. | 3.98B | -0.81% | 79,837 | 2.16B |
| 184 | PBLS | Parabilis Medicines, Inc. | 3.95B | -1.02% | 222,844 | 148.00K |
| 185 | XENE | Xenon Pharmaceuticals Inc. | 3.81B | 5.83% | 2,225,992 | 7.50M |
| 186 | LEGN | Legend Biotech Corporation | 3.76B | -2.34% | 856,579 | 1.27B |
| 187 | CELC | Celcuity Inc. | 3.76B | -3.29% | 457,722 | - |
| 188 | IDYA | IDEAYA Biosciences, Inc. | 3.73B | 0.49% | 190,899 | 234.13M |
| 189 | NVST | Envista Holdings Corporation | 3.72B | -1.32% | 893,386 | 2.86B |
| 190 | VCYT | Veracyte, Inc. | 3.69B | -0.35% | 528,358 | 561.90M |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.68B | -1.81% | 117,339 | 825.34M |
| 192 | TLX | Telix Pharmaceuticals Limited | 3.67B | -1.64% | 97,970 | 890.79M |
| 193 | VKTX | Viking Therapeutics, Inc. | 3.65B | -4.08% | 3,104,859 | - |
| 194 | OGN | Organon & Co. | 3.61B | 0.26% | 877,834 | 6.13B |
| 195 | PLSE | Pulse Biosciences, Inc. | 3.59B | 0.82% | 147,525 | 1.19M |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.55B | -2.89% | 709,195 | -665.00K |
| 197 | NHC | National HealthCare Corporation | 3.49B | 1.45% | 45,777 | 1.56B |
| 198 | WRBY | Warby Parker Inc. | 3.48B | 1.22% | 2,401,933 | 911.61M |
| 199 | ACAD | Acadia Pharmaceuticals Inc. | 3.44B | -0.87% | 1,001,787 | 1.14B |
| 200 | ELVN | Enliven Therapeutics, Inc. | 3.42B | 1.72% | 400,127 | - |
| 201 | OPCH | Option Care Health, Inc. | 3.40B | 0.80% | 597,412 | 5.69B |
| 202 | CDNA | CareDx, Inc. | 3.39B | 0.86% | 1,054,665 | 458.09M |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.35B | -2.87% | 339,947 | 606.33M |
| 204 | DNLI | Denali Therapeutics Inc. | 3.31B | 0.29% | 612,871 | 3.60M |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.29B | 0.15% | 338,726 | 117.00M |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.26B | -1.89% | 459,828 | 463.98M |
| 207 | RGC | Regencell Bioscience Holdings Limited | 3.17B | 2.73% | 47,853 | - |
| 208 | DYN | Dyne Therapeutics, Inc. | 3.04B | 0.99% | 1,863,271 | - |
| 209 | PGEN | Precigen, Inc. | 2.97B | -3.04% | 2,468,470 | 85.72M |
| 210 | NAMS | NewAmsterdam Pharma Company N.V. | 2.95B | 1.48% | 687,147 | 7.12M |
| 211 | ZLAB | Zai Lab Limited | 2.90B | -2.09% | 215,599 | 449.61M |
| 212 | MBX | MBX Biosciences, Inc. | 2.80B | -0.99% | 162,297 | - |
| 213 | ATRC | AtriCure, Inc. | 2.76B | -3.45% | 824,743 | 569.62M |
| 214 | TMDX | TransMedics Group, Inc. | 2.74B | -5.15% | 400,723 | 668.47M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.74B | 1.25% | 951,726 | 2.60B |
| 216 | NEOG | Neogen Corporation | 2.73B | -2.03% | 1,231,936 | 870.40M |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.60B | 0.71% | 125,166 | 1.46B |
| 218 | PRVA | Privia Health Group, Inc. | 2.59B | 3.17% | 648,077 | 2.36B |
| 219 | HCM | HUTCHMED (China) Limited | 2.57B | 0.07% | 20,136 | 549.12M |
| 220 | BKD | Brookdale Senior Living Inc. | 2.56B | -1.20% | 2,367,330 | 2.93B |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.53B | -0.43% | 679,803 | 158.00K |
| 222 | ACHC | Acadia Healthcare Company, Inc. | 2.51B | -1.82% | 367,211 | 3.37B |
| 223 | BEAM | Beam Therapeutics Inc. | 2.48B | 1.60% | 865,188 | 156.04M |
| 224 | IRON | Disc Medicine, Inc. | 2.48B | -1.34% | 265,008 | - |
| 225 | NRIX | Nurix Therapeutics, Inc. | 2.48B | 0.76% | 371,884 | 36.77M |
| 226 | SUPN | Supernus Pharmaceuticals, Inc. | 2.48B | -1.05% | 161,889 | 830.44M |
| 227 | AXGN | Axogen, Inc. | 2.42B | -1.72% | 389,612 | 251.17M |
| 228 | IMNM | Immunome, Inc. | 2.41B | -1.32% | 542,546 | 4.02M |
| 229 | LQDA | Liquidia Corporation | 2.37B | -12.59% | 15,981,914 | 450.91M |
| 230 | ALMR | Alamar Biosciences, Inc. | 2.33B | -1.47% | 141,341 | 100.42M |
| 231 | SLS | SELLAS Life Sciences Group, Inc. | 2.32B | -6.78% | 3,020,949 | - |
| 232 | UFPT | UFP Technologies, Inc. | 2.31B | 0.61% | 62,897 | 631.64M |
| 233 | BFLY | Butterfly Network, Inc. | 2.30B | -3.63% | 2,599,592 | 112.14M |
| 234 | NEO | NeoGenomics, Inc. | 2.30B | -2.61% | 1,094,496 | 766.30M |
| 235 | SDGR | Schrödinger, Inc. | 2.29B | -1.35% | 3,260,127 | 259.04M |
| 236 | HRMY | Harmony Biosciences Holdings, Inc. | 2.29B | 0.05% | 449,381 | 959.90M |
| 237 | VERA | Vera Therapeutics, Inc. | 2.28B | -1.90% | 543,982 | - |
| 238 | ADMA | ADMA Biologics, Inc. | 2.28B | 1.55% | 1,446,105 | 512.28M |
| 239 | CLOV | Clover Health Investments, Corp. | 2.24B | -2.32% | 2,086,161 | 2.48B |
| 240 | PHVS | Pharvaris N.V. | 2.22B | -0.19% | 312,706 | - |
| 241 | VRDN | Viridian Therapeutics, Inc. | 2.22B | -5.03% | 1,420,553 | 71.13M |
| 242 | RXRX | Recursion Pharmaceuticals, Inc. | 2.19B | -1.09% | 9,836,636 | 54.86M |
| 243 | ADRX | ADARx Pharmaceuticals, Inc. | 2.17B | -2.81% | 474,335 | 6.13M |
| 244 | WGS | GeneDx Holdings Corp. | 2.16B | 0.26% | 458,799 | 454.43M |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.15B | -0.87% | 304,543 | 1.10B |
| 246 | TRLV | Trulieve Cannabis Corp. | 2.15B | 2.39% | 1,609,648 | 1.14B |
| 247 | BHC | Bausch Health Companies Inc. | 2.15B | -1.54% | 748,674 | 10.85B |
| 248 | MLYS | Mineralys Therapeutics, Inc. | 2.14B | -3.78% | 733,286 | - |
| 249 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -0.83% | 389,827 | 311.51M |
| 250 | GPCR | Structure Therapeutics Inc. | 2.13B | -4.29% | 989,412 | - |
| 251 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.10B | -1.56% | 2,720,114 | 940.61M |
| 252 | TRVI | Trevi Therapeutics, Inc. | 2.08B | 1.71% | 1,210,324 | - |
| 253 | ADUS | Addus HomeCare Corporation | 2.06B | 1.86% | 85,374 | 1.48B |
| 254 | VCEL | Vericel Corporation | 2.06B | 0.19% | 149,217 | 306.30M |
| 255 | INSP | Inspire Medical Systems, Inc. | 2.04B | 1.90% | 350,136 | 898.74M |
| 256 | MD | Pediatrix Medical Group, Inc. | 2.03B | -0.39% | 152,174 | 1.95B |
| 257 | BHVN | Biohaven Ltd. | 2.03B | 0.67% | 734,021 | - |
| 258 | ALVO | Alvotech | 2.01B | -2.76% | 745,173 | 494.61M |
| 259 | URGN | UroGen Pharma Ltd. | 2.01B | 1.00% | 175,578 | 188.73M |
| 260 | PRGO | Perrigo Company plc | 2.01B | -2.10% | 1,007,526 | 4.14B |
| 261 | PVLA | Palvella Therapeutics, Inc. | 1.97B | -1.08% | 141,501 | - |
| 262 | NUVB | Nuvation Bio Inc. | 1.95B | -0.71% | 1,531,469 | 169.90M |
| 263 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | -1.68% | 512,970 | 98.34M |
| 264 | LKFT | Lakefront Biotherapeutics NV | 1.95B | -2.09% | 161,999 | 1.13B |
| 265 | VIR | Vir Biotechnology, Inc. | 1.94B | 2.59% | 1,139,060 | 303.23M |
| 266 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.94B | -2.55% | 1,391,955 | 208.78M |
| 267 | PGNY | Progyny, Inc. | 1.93B | -0.30% | 496,798 | 1.31B |
| 268 | SRPT | Sarepta Therapeutics, Inc. | 1.90B | -1.21% | 1,084,053 | 1.97B |
| 269 | ESTA | Establishment Labs Holdings Inc. | 1.90B | -0.86% | 103,847 | 245.82M |
| 270 | ZBIO | Zenas BioPharma, Inc. | 1.88B | 7.12% | 338,433 | 1.00M |
| 271 | NVCR | NovoCure Limited | 1.88B | 1.19% | 505,723 | 699.19M |
| 272 | MESO | Mesoblast Limited | 1.87B | -1.71% | 174,344 | 120.25M |
| 273 | ZYME | Zymeworks Inc. | 1.86B | -0.83% | 169,817 | 37.13M |
| 274 | LMAT | LeMaitre Vascular, Inc. | 1.86B | -1.76% | 120,121 | 262.43M |
| 275 | ABSI | Absci Corporation | 1.85B | 0.09% | 2,974,448 | 1.56M |
| 276 | XNCR | Xencor, Inc. | 1.84B | -0.56% | 244,654 | 104.97M |
| 277 | GENB | Generate Biomedicines, Inc. | 1.84B | -4.53% | 579,024 | 26.48M |
| 278 | FTRE | Fortrea Holdings Inc. | 1.83B | -3.46% | 653,096 | 2.68B |
| 279 | SEPN | Septerna, Inc. | 1.81B | -0.66% | 283,557 | 98.88M |
| 280 | ASTH | Astrana Health, Inc. | 1.81B | -0.45% | 98,251 | 3.84B |
| 281 | BLFS | BioLife Solutions, Inc. | 1.81B | -4.97% | 540,761 | 106.69M |
| 282 | SNDA | Sonida Senior Living, Inc. | 1.80B | 1.01% | 186,502 | 481.07M |
| 283 | NVAX | Novavax, Inc. | 1.77B | -0.93% | 1,696,489 | 413.80M |
| 284 | NTLA | Intellia Therapeutics, Inc. | 1.75B | 3.73% | 3,775,013 | 59.51M |
| 285 | XRAY | DENTSPLY SIRONA Inc. | 1.75B | -1.19% | 3,286,966 | 3.64B |
| 286 | SGRY | Surgery Partners, Inc. | 1.73B | -3.68% | 545,786 | 3.37B |
| 287 | PSNL | Personalis, Inc. | 1.73B | -0.49% | 952,003 | 69.67M |
| 288 | XERS | Xeris Biopharma Holdings, Inc. | 1.71B | -2.09% | 1,243,601 | 335.41M |
| 289 | QURE | uniQure N.V. | 1.70B | 1.72% | 1,479,497 | 18.67M |
| 290 | STOK | Stoke Therapeutics, Inc. | 1.70B | 1.21% | 281,285 | 27.59M |
| 291 | FRNM | Freenome, Inc. | 1.69B | 0.06% | 249,843 | 35.41M |
| 292 | OCUL | Ocular Therapeutix, Inc. | 1.68B | -0.20% | 1,968,617 | 52.06M |
| 293 | CMPS | COMPASS Pathways plc | 1.68B | -2.41% | 2,101,662 | - |
| 294 | KMTS | Kestra Medical Technologies, Ltd. | 1.66B | -1.70% | 164,931 | 106.73M |
| 295 | RAPP | Rapport Therapeutics, Inc. | 1.63B | 1.19% | 136,222 | 20.00M |
| 296 | SNDX | Syndax Pharmaceuticals, Inc. | 1.63B | -2.85% | 664,973 | 252.25M |
| 297 | NKTR | Nektar Therapeutics | 1.63B | -21.30% | 3,702,264 | 54.59M |
| 298 | ALHC | Alignment Healthcare, Inc. | 1.62B | -4.41% | 6,037,653 | 4.58B |
| 299 | IMCR | Immunocore Holdings plc | 1.59B | 2.18% | 347,339 | 430.78M |
| 300 | NBTX | Nanobiotix S.A. | 1.59B | -7.99% | 143,920 | 13.15M |
| 301 | TSHA | Taysha Gene Therapies, Inc. | 1.58B | -0.41% | 1,150,115 | 5.49M |
| 302 | GHRS | GH Research PLC | 1.57B | -2.70% | 108,560 | - |
| 303 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | -0.01% | 92,657 | 978.38M |
| 304 | ATEC | Alphatec Holdings, Inc. | 1.53B | -3.78% | 1,279,870 | 815.05M |
| 305 | OMCL | Omnicell, Inc. | 1.53B | -1.47% | 148,077 | 1.25B |
| 306 | AZTA | Azenta, Inc. | 1.51B | -1.26% | 263,469 | 613.81M |
| 307 | MAZE | Maze Therapeutics, Inc. | 1.50B | -0.37% | 217,505 | 20.00M |
| 308 | ETON | Eton Pharmaceuticals, Inc. | 1.50B | 1.83% | 825,088 | 105.60M |
| 309 | INVA | Innoviva, Inc. | 1.49B | -2.50% | 329,675 | 440.00M |
| 310 | NUTX | Nutex Health Inc. | 1.49B | 2.56% | 69,554 | 846.72M |
| 311 | INBX | Inhibrx Biosciences, Inc. | 1.48B | 0.38% | 124,653 | 1.30M |
| 312 | RARE | Ultragenyx Pharmaceutical Inc. | 1.47B | -0.20% | 1,499,144 | 717.00M |
| 313 | TYRA | Tyra Biosciences, Inc. | 1.47B | -2.15% | 450,082 | - |
| 314 | AVBP | ArriVent BioPharma, Inc. | 1.47B | -1.68% | 171,301 | - |
| 315 | PAHC | Phibro Animal Health Corporation | 1.47B | 1.08% | 81,632 | 1.52B |
| 316 | ARDT | Ardent Health, Inc. | 1.45B | -0.58% | 116,348 | 6.41B |
| 317 | ANAB | AnaptysBio, Inc. | 1.45B | -3.50% | 248,440 | 106.09M |
| 318 | KLRA | Kailera Therapeutics, Inc. | 1.44B | -2.45% | 527,859 | - |
| 319 | AAPG | Ascentage Pharma Group International | 1.44B | -4.05% | 3,897 | 94.61M |
| 320 | COAG | Hemab Therapeutics Holdings, Inc. | 1.44B | -0.32% | 253,817 | - |
| 321 | KRSA | Korsana Biosciences, Inc. | 1.43B | -1.86% | 6,598 | - |
| 322 | CERT | Certara, Inc. | 1.43B | 1.90% | 2,270,157 | 421.75M |
| 323 | BRVE | Braveheart Bio, Inc. | 1.41B | 6.24% | 364,810 | - |
| 324 | AMN | AMN Healthcare Services, Inc. | 1.41B | 1.20% | 216,162 | 3.43B |
| 325 | HCSG | Healthcare Services Group, Inc. | 1.40B | 0.10% | 561,678 | 1.86B |
| 326 | AGL | agilon health, inc. | 1.40B | 4.47% | 121,545 | 5.92B |
| 327 | CNMD | CONMED Corporation | 1.39B | 0.71% | 81,288 | 1.37B |
| 328 | OMER | Omeros Corporation | 1.38B | 0.42% | 496,903 | 38.42M |
| 329 | DRTS | Alpha Tau Medical Ltd. | 1.36B | -1.17% | 151,581 | - |
| 330 | PNTG | The Pennant Group, Inc. | 1.36B | -0.33% | 114,073 | 1.10B |
| 331 | KARD | Kardigan, Inc. | 1.35B | -2.24% | 480,467 | - |
| 332 | ORIC | ORIC Pharmaceuticals, Inc. | 1.35B | -3.49% | 766,813 | - |
| 333 | MNKD | MannKind Corporation | 1.31B | 4.36% | 5,563,715 | 393.63M |
| 334 | SVRA | Savara Inc. | 1.30B | -0.58% | 1,195,599 | - |
| 335 | DMRA | Damora Therapeutics, Inc. | 1.29B | -2.07% | 159,669 | - |
| 336 | REPL | Replimune Group, Inc. | 1.27B | 1.89% | 1,277,852 | - |
| 337 | OMDA | Omada Health, Inc. | 1.26B | -1.08% | 745,699 | 309.76M |
| 338 | IART | Integra LifeSciences Holdings Corporation | 1.26B | -0.55% | 216,209 | 1.65B |
| 339 | USPH | U.S. Physical Therapy, Inc. | 1.26B | -1.76% | 60,481 | 804.27M |
| 340 | TRAX | First Tracks Biotherapeutics, Inc. | 1.26B | -0.85% | 236,463 | - |
| 341 | AVLN | Avalyn Pharma Inc. | 1.24B | -1.86% | 202,997 | - |
| 342 | LBRX | LB Pharmaceuticals Inc | 1.23B | -0.89% | 92,806 | - |
| 343 | BCAX | Bicara Therapeutics Inc. | 1.23B | -0.43% | 214,018 | - |
| 344 | CRON | Cronos Group Inc. | 1.22B | -2.27% | 808,697 | 179.09M |
| 345 | INNV | InnovAge Holding Corp. | 1.21B | 0.45% | 225,460 | 989.71M |
| 346 | IMTX | Immatics N.V. | 1.19B | -0.91% | 209,480 | 47.65M |
| 347 | OPK | OPKO Health, Inc. | 1.18B | -2.17% | 1,092,673 | 587.90M |
| 348 | HROW | Harrow, Inc. | 1.16B | 0.32% | 284,116 | 275.59M |
| 349 | BVS | Bioventus Inc. | 1.16B | 0.81% | 174,277 | 581.85M |
| 350 | TNDM | Tandem Diabetes Care, Inc. | 1.14B | 0.18% | 849,194 | 1.04B |
| 351 | LTGO | Latigo Biotherapeutics, Inc. | 1.13B | 1.92% | 139,584 | - |
| 352 | STAA | STAAR Surgical Company | 1.11B | -1.81% | 277,809 | 339.59M |
| 353 | VOR | Vor Biopharma Inc. | 1.11B | -1.99% | 441,745 | - |
| 354 | GDRX | GoodRx Holdings, Inc. | 1.10B | -1.82% | 403,973 | 785.23M |
| 355 | IRMD | IRADIMED CORPORATION | 1.10B | -0.32% | 37,261 | 86.34M |
| 356 | CSTL | Castle Biosciences, Inc. | 1.09B | 0.76% | 216,280 | 357.28M |
| 357 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.09B | -0.46% | 203,236 | 730.02M |
| 358 | AORT | Artivion, Inc. | 1.09B | -2.28% | 200,790 | 471.47M |
| 359 | ENOV | Enovis Corporation | 1.06B | 0.99% | 412,793 | 2.30B |
| 360 | MGTX | MeiraGTx Holdings plc | 1.06B | - | 378,631 | 397.50M |
| 361 | SPTX | Seaport Therapeutics, Inc. | 1.06B | -2.21% | 65,769 | - |
| 362 | TDOC | Teladoc Health, Inc. | 1.05B | -0.52% | 1,891,676 | 2.49B |
| 363 | AKTS | Aktis Oncology, Inc. | 1.05B | -3.49% | 112,618 | 10.06M |
| 364 | JANX | Janux Therapeutics, Inc. | 1.04B | -1.45% | 284,042 | 24.00M |
| 365 | ODTX | Odyssey Therapeutics, Inc. | 1.03B | -3.65% | 136,560 | 99.00K |
| 366 | ANRO | Alto Neuroscience, Inc. | 1.02B | 1.49% | 237,672 | - |
| 367 | ANL | Adlai Nortye Group Ltd. | 1.01B | -1.75% | 19,266 | 18.06M |
| 368 | PCRX | Pacira BioSciences, Inc. | 1.01B | 1.16% | 163,070 | 746.16M |
| 369 | BBNX | Beta Bionics, Inc. | 1.00B | 0.26% | 508,318 | 119.01M |
| 370 | PRCT | PROCEPT BioRobotics Corporation | 985.11M | -5.60% | 502,018 | 337.34M |
| 371 | MLTX | MoonLake Immunotherapeutics | 982.98M | -1.28% | 544,363 | - |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 981.89M | -0.29% | 161,032 | 1.04B |
| 373 | CGEM | Cullinan Therapeutics, Inc. | 970.47M | -1.76% | 349,025 | - |
| 374 | KURA | Kura Oncology, Inc. | 969.67M | 1.77% | 1,262,898 | 77.23M |
| 375 | GLUE | Monte Rosa Therapeutics, Inc. | 964.89M | -5.20% | 1,731,963 | 28.73M |
| 376 | CRVS | Corvus Pharmaceuticals, Inc. | 964.03M | -0.52% | 465,908 | - |
| 377 | APMD | Apnimed, Inc. | 960.84M | 5.34% | 484,354 | 115.12M |
| 378 | ALMS | Alumis Inc. | 951.35M | -0.54% | 826,312 | 7.40M |
| 379 | SLBT | SL Science Holding Limited | 946.64M | -2.35% | 27,280 | 3.27M |
| 380 | CBLL | CeriBell, Inc. | 931.05M | -0.53% | 122,213 | 101.96M |
| 381 | HSTM | HealthStream, Inc. | 926.44M | 1.92% | 56,784 | 321.12M |
| 382 | ABUS | Arbutus Biopharma Corporation | 918.01M | -2.93% | 6,137,351 | 181.72M |
| 383 | JBIO | Jade Biosciences, Inc. | 898.63M | 0.57% | 447,091 | - |
| 384 | SANA | Sana Biotechnology, Inc. | 898.08M | 2.92% | 2,222,479 | - |
| 385 | SGP | SpyGlass Pharma, Inc. | 889.38M | 2.27% | 43,826 | - |
| 386 | RIGL | Rigel Pharmaceuticals, Inc. | 887.48M | -1.33% | 96,130 | 276.79M |
| 387 | HELP | Cybin Inc. | 884.76M | -1.46% | 914,077 | - |
| 388 | IVA | Inventiva S.A. | 884.11M | -3.79% | 4,327,240 | 2.81M |
| 389 | IMMX | Immix Biopharma, Inc. | 865.51M | 0.34% | 918,306 | - |
| 390 | ARDX | Ardelyx, Inc. | 844.75M | -0.88% | 1,766,563 | 450.89M |
| 391 | OBX | Obsidian Therapeutics, Inc. | 844.44M | -0.44% | 102,564 | - |
| 392 | ATTO | Attovia Therapeutics, Inc. | 829.03M | 5.95% | 215,422 | 1.80M |
| 393 | LXRX | Lexicon Pharmaceuticals, Inc. | 827.62M | -0.80% | 918,651 | 41.47M |
| 394 | SIBN | SI-BONE, Inc. | 826.90M | -1.86% | 226,719 | 213.60M |
| 395 | DNA | Ginkgo Bioworks Holdings, Inc. | 824.92M | -4.52% | 1,777,359 | 132.42M |
| 396 | ANNX | Annexon, Inc. | 823.72M | 2.72% | 1,258,423 | - |
| 397 | AVTX | Avalo Therapeutics, Inc. | 813.03M | -1.11% | 317,979 | 59.00K |
| 398 | INMD | InMode Ltd. | 812.78M | -0.21% | 333,485 | 374.63M |
| 399 | CADL | Candel Therapeutics, Inc. | 799.62M | 0.10% | 535,059 | - |
| 400 | FDMT | 4D Molecular Therapeutics, Inc. | 798.28M | 0.98% | 246,181 | 92.01M |
| 401 | ACHV | Achieve Life Sciences, Inc. | 794.41M | -4.57% | 587,909 | - |
| 402 | DSGN | Design Therapeutics, Inc. | 788.53M | 0.24% | 122,346 | - |
| 403 | WVE | Wave Life Sciences, Inc. | 784.25M | 7.57% | 2,319,822 | 65.37M |
| 404 | GERN | Geron Corporation | 783.82M | -0.81% | 7,428,577 | 204.56M |
| 405 | AHG | Akso Health Group | 779.60M | 1.11% | 160,185 | 13.83M |
| 406 | VREX | Varex Imaging Corporation | 778.05M | 0.05% | 200,253 | 865.00M |
| 407 | SLDB | Solid Biosciences Inc. | 767.73M | -0.97% | 611,117 | - |
| 408 | AHCO | AdaptHealth Corp. | 759.10M | 0.89% | 774,743 | 3.36B |
| 409 | PACB | Pacific Biosciences of California, Inc. | 756.87M | 2.74% | 16,789,763 | 159.27M |
| 410 | GYRE | Gyre Therapeutics, Inc. | 754.96M | -2.86% | 42,666 | 109.82M |
| 411 | CTKB | Cytek Biosciences, Inc. | 749.35M | -3.27% | 647,176 | 206.71M |
| 412 | AVR | Anteris Technologies Global Corp. | 744.58M | -1.67% | 450,360 | 2.24M |
| 413 | OLMA | Olema Pharmaceuticals, Inc. | 740.23M | -2.08% | 522,754 | - |
| 414 | FTH | Faeth Therapeutics, Inc. | 735.81M | -4.25% | 126,011 | - |
| 415 | VSTM | Verastem, Inc. | 733.56M | 0.62% | 601,676 | 87.53M |
| 416 | STTK | Shattuck Labs, Inc. | 726.63M | 6.16% | 1,041,271 | 1.00M |
| 417 | GMRS | GMR Solutions Inc. | 721.26M | -3.63% | 1,316,369 | 5.88B |
| 418 | OABI | OmniAb, Inc. | 721.14M | - | 1,195,687 | 38.46M |
| 419 | COLL | Collegium Pharmaceutical, Inc. | 717.69M | 1.03% | 381,475 | 808.21M |
| 420 | PHAR | Pharming Group N.V. | 713.09M | 0.20% | 8,641 | 366.48M |
| 421 | QDEL | QuidelOrtho Corporation | 708.38M | -1.99% | 1,089,889 | 2.67B |
| 422 | DBVT | DBV Technologies S.A. | 696.94M | -4.93% | 330,535 | 5.04M |
| 423 | ACRS | Aclaris Therapeutics, Inc. | 688.89M | -11.03% | 2,187,418 | 8.22M |
| 424 | NVCT | Nuvectis Pharma, Inc. | 685.68M | -0.36% | 77,734 | - |
| 425 | ETRA | Electra Therapeutics, Inc. | 682.28M | -3.38% | 504,325 | - |
| 426 | MDXG | MiMedx Group, Inc. | 679.24M | - | 520,399 | 355.17M |
| 427 | SOPH | SOPHiA GENETICS SA | 675.91M | -5.25% | 289,603 | 86.17M |
| 428 | CLYM | Climb Bio, Inc. | 663.39M | 0.70% | 437,804 | - |
| 429 | STLN | Starling Oncology, Inc. | 647.17M | 0.47% | 452,376 | 587.24M |
| 430 | SLN | Silence Therapeutics plc | 645.44M | -1.92% | 797,975 | 615.00K |
| 431 | PHR | Phreesia, Inc. | 641.81M | 0.10% | 235,081 | 507.79M |
| 432 | AURA | Aura Biosciences, Inc. | 636.23M | -2.31% | 360,196 | - |
| 433 | ANGO | AngioDynamics, Inc. | 630.73M | -0.78% | 175,575 | 320.17M |
| 434 | ZVRA | Zevra Therapeutics, Inc. | 628.28M | -3.56% | 384,422 | 136.07M |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 627.91M | -4.28% | 1,362,597 | 389.32M |
| 436 | EVO | Evotec SE | 625.74M | -2.34% | 18,029 | 819.47M |
| 437 | CBIO | Crescent Biopharma, Inc. | 615.05M | -1.51% | 49,085 | 11.88M |
| 438 | EPRX | Eupraxia Pharmaceuticals Inc. | 603.06M | -9.45% | 1,789,427 | - |
| 439 | BLSM | BlossomHill Therapeutics, Inc. | 602.64M | 1.72% | 86,673 | - |
| 440 | SGMT | Sagimet Biosciences Inc. | 596.72M | -2.83% | 872,258 | - |
| 441 | CRMD | CorMedix Inc. | 593.16M | -1.17% | 359,608 | 462.25M |
| 442 | FLGT | Fulgent Genetics, Inc. | 592.40M | -2.23% | 97,769 | 323.93M |
| 443 | WEAV | Weave Communications, Inc. | 590.79M | 0.07% | 682,137 | 257.79M |
| 444 | CTMX | CytomX Therapeutics, Inc. | 583.97M | -1.47% | 1,173,400 | 18.30M |
| 445 | PHAT | Phathom Pharmaceuticals, Inc. | 575.07M | -0.82% | 365,253 | 239.66M |
| 446 | KIDS | OrthoPediatrics Corp. | 571.54M | -1.71% | 98,736 | 252.72M |
| 447 | SSII | SS Innovations International, Inc. | 569.09M | -4.70% | 67,644 | 52.40M |
| 448 | YDES | YD Bio Limited | 565.23M | 7.55% | 177,024 | 1.24M |
| 449 | AQST | Aquestive Therapeutics, Inc. | 562.29M | -3.24% | 1,319,798 | 54.09M |
| 450 | VALN | Valneva SE | 557.50M | -3.80% | 28,753 | 163.30M |
| 451 | ALLO | Allogene Therapeutics, Inc. | 554.51M | 0.31% | 2,565,802 | 4.64M |
| 452 | OCS | Oculis Holding AG | 550.65M | -4.50% | 368,271 | 1.45M |
| 453 | MPLT | MapLight Therapeutics, Inc. | 547.42M | -3.34% | 125,312 | - |
| 454 | ALT | Altimmune, Inc. | 544.65M | -2.10% | 2,260,065 | 31.00K |
| 455 | NGNE | Neurogene Inc. | 544.31M | -2.23% | 66,412 | 925.00K |
| 456 | PRME | Prime Medicine, Inc. | 542.61M | -0.16% | 1,040,912 | 4.07M |
| 457 | DCTH | Delcath Systems, Inc. | 541.30M | -2.32% | 134,521 | 95.42M |
| 458 | SENS | Senseonics Holdings, Inc. | 536.14M | -0.29% | 219,989 | 48.55M |
| 459 | MNPR | Monopar Therapeutics Inc. | 535.09M | 0.06% | 85,290 | - |
| 460 | CAPR | Capricor Therapeutics, Inc. | 529.65M | -3.80% | 2,652,157 | 11.13M |
| 461 | MASS | 908 Devices Inc. | 519.98M | 1.94% | 270,958 | 60.84M |
| 462 | PBYI | Puma Biotechnology, Inc. | 519.04M | 1.26% | 167,438 | 231.24M |
| 463 | EOLS | Evolus, Inc. | 517.17M | -2.12% | 453,625 | 316.49M |
| 464 | PROK | ProKidney Corp. | 515.46M | 2.71% | 478,659 | 818.00K |
| 465 | BWAY | BrainsWay Ltd. | 509.79M | -3.48% | 95,572 | 60.70M |
| 466 | AUTL | Autolus Therapeutics plc | 507.04M | -1.80% | 922,998 | 117.39M |
| 467 | RGNX | REGENXBIO Inc. | 506.98M | 1.99% | 600,453 | 174.48M |
| 468 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 469 | ENTX | Entera Bio Ltd. | 503.84M | - | 215,627 | 42.00K |
| 470 | ARVN | Arvinas, Inc. | 500.86M | -0.97% | 293,634 | 316.70M |
| 471 | TCMD | Tactile Systems Technology, Inc. | 499.94M | -0.99% | 56,803 | 350.31M |
| 472 | TLRY | Tilray Brands, Inc. | 498.65M | -2.93% | 4,250,704 | 915.45M |
| 473 | SGHT | Sight Sciences, Inc. | 495.79M | -3.85% | 201,060 | 83.38M |
| 474 | GLAS | Glass House Brands Inc. | 494.77M | -6.42% | 2,210,097 | 176.98M |
| 475 | DRUG | Bright Minds Biosciences Inc. | 488.67M | -0.19% | 101,720 | - |
| 476 | OVID | Ovid Therapeutics Inc. | 488.24M | 0.40% | 696,580 | 1.58M |
| 477 | TKNO | Alpha Teknova, Inc. | 480.51M | 0.56% | 116,710 | 43.70M |
| 478 | CTNM | Contineum Therapeutics, Inc. | 479.29M | -5.07% | 355,407 | - |
| 479 | ASMB | Assembly Biosciences, Inc. | 476.59M | -0.35% | 114,661 | 74.85M |
| 480 | KMDA | Kamada Ltd. | 475.28M | -2.36% | 55,825 | 191.85M |
| 481 | NRC | NRC Health | 474.91M | 1.32% | 40,725 | 140.00M |
| 482 | AGMB | AgomAb Therapeutics NV | 471.30M | -13.78% | 320,296 | - |
| 483 | CERS | Cerus Corporation | 469.55M | -2.10% | 794,493 | 221.55M |
| 484 | NPCE | NeuroPace, Inc. | 465.09M | -1.53% | 85,491 | 106.99M |
| 485 | DMAC | DiaMedica Therapeutics Inc. | 458.37M | 2.78% | 123,195 | - |
| 486 | TECX | Tectonic Therapeutic, Inc. | 454.33M | -0.21% | 169,317 | - |
| 487 | SRTA | Strata Critical Medical, Inc. | 440.56M | -2.54% | 845,774 | 255.98M |
| 488 | PRTA | Prothena Corporation plc | 437.65M | 1.73% | 188,343 | 54.53M |
| 489 | RZLT | Rezolute, Inc. | 432.17M | -0.48% | 471,694 | - |
| 490 | SPRY | ARS Pharmaceuticals, Inc. | 429.61M | 0.23% | 995,017 | 116.93M |
| 491 | KYTX | Kyverna Therapeutics, Inc. | 415.59M | -1.18% | 409,123 | - |
| 492 | EIKN | Eikon Therapeutics, Inc. | 411.65M | -5.47% | 293,765 | - |
| 493 | AGEN | Agenus Inc. | 410.14M | -8.26% | 1,033,426 | 132.69M |
| 494 | TTRX | Turn Therapeutics Inc. | 409.73M | -4.41% | 39,010 | - |
| 495 | ZURA | Zura Bio Limited | 405.36M | 1.68% | 2,090,210 | - |
| 496 | MYGN | Myriad Genetics, Inc. | 403.64M | -2.09% | 518,611 | 806.60M |
| 497 | AVIR | Atea Pharmaceuticals, Inc. | 402.63M | -3.65% | 138,398 | - |
| 498 | PRLD | Prelude Therapeutics Incorporated | 401.68M | -0.26% | 242,238 | 22.42M |
| 499 | RLMD | Relmada Therapeutics, Inc. | 401.08M | -0.27% | 466,455 | - |
| 500 | CCCC | C4 Therapeutics, Inc. | 401.06M | -2.10% | 763,214 | 35.04M |